|
ACCP and ACAAI release guidelines on inhaled aerosol therapy for patients with pulmonary disease.(Practice Guidelines)(American College of Chest Physicians)(American College of Asthma, Allergy, and Immunology)
Publication: American Family Physician Publication Date: 01-SEP-05 Author: Huntzinger, Amber
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2005 American Academy of Family Physicians
The American College of Chest Physicians (ACCP) and the American College of Asthma, Allergy, and Immunology (ACAAI) have released evidence-based recommendations to guide physicians in choosing aerosol devices and drug formulations for patients with pulmonary disease. Investigators assessed the available scientific evidence addressing the question of whether device selection affects efficacy and the adverse effects of treatment. The report was published in the January 2005 issue of Chest.
The authors conducted a meta-analysis of randomized controlled trials (RCTs) that evaluated patients receiving inhaled corticosteroids, [beta.sub.2] agonists, or anticholinergics delivered through a metered-dose...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from American Family Physician |
CDC reports on U.S. heat-related mortality.(Practice Guidelines Briefs...
September 01, 2005
|
Cholesterol and risk of MI in older adults.(Tips)
September 01, 2005
|
Do antioxidants increase mortality?(Tips)
September 01, 2005
|
Effects of low literacy on diabetes management.(Tips)
September 01, 2005
|
Corticosteroids and mortality in patients with head trauma.(Tips)
September 01, 2005
|
|
| Find companies classified under Offices clinics of medical doctors |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
